Log In
Print this Print this

nilvadipine formulation (ARC029)

  Manage Alerts
Collapse Summary General Information
Company Archer Pharmaceuticals Inc.
DescriptionSoluble amyloid reducing/clearing formulation of nilvadipine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today